十味通脉丸治疗肢体动脉硬化性闭塞症临床研究  

A clinical study on treating limb arteriosclerosis obliterans with Shiwei Tongmai Wan

作　　者：潘广军 于建娜 

机构地区：[1]宁阳县中医院,山东宁阳271400

出　　处：《中医临床研究》2014年第22期61-63,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨中药治疗肢体动脉硬化性闭塞症的临床疗效。方法:将肢体动脉硬化性闭塞症200例随机分为十味通脉丸治疗组(n=100),通塞脉片对照组(n=100)。结果:治疗组治愈率56%,全部有效。十味通脉丸治疗组明显优于通塞脉片对照组(P<0.05),十味通脉丸有降低血脂作用,治疗前后比较,TC、HDL、LDL、AI有显著差异(P<0.01),血流变学的多数指标亦有明显降低(P<0.05)。结论:十味通脉丸治疗肢体动脉硬化性闭塞症有明显疗效。Objective：To discuss clinical effects of TCM medicine on limb arteriosclerosis obliterans. Methods：200 patients were divided into two groups, 100 patients for each. The treatment group was given Shiwei Tongmai Wan, while the control group was given Tongsaimai tablet. Results：The curative rate （56%） and the total efficiency in the treatment group were better than those in the control （P〈0.05）. Compared with prior-treatment, Shiwei Tongmai Wan could improve the level of plasma lipoprotein （P〈0.01）, reduce blood lipids and most indicators of blood rheology （P〈0.05）. Conclusion： Clinical efficiency of Shiwei Tongmai Wan was confirmed.

关 键 词：十味通脉丸 治疗肢体动脉硬化性闭塞症 临床研究 

分 类 号：R331.33[医药卫生—人体生理学]